Acronym |
  |
Trial Name |
|
|
|
Aggrastat to Zocor |
|
|
Aspirin for Asymptomatic Atherosclerosis |
|
|
African American Study of Kidney disease and hypertension |
|
|
Appropriate Blood pressure Control in Diabetes |
|
|
Appropriate Blood pressure Control in Diabetes – Part 2 with Valsartan |
|
|
Angioplasty to Blunt the rise of troponin in Acute coronary syndromes Randomized for an immediate or Delayed intervention |
|
|
Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia |
|
|
Asymptomatic Carotid Artery Plaque Study |
|
|
Asymptomatic Carotid Atherosclerosis Study |
|
|
Accupril Canadian Clinical Evaluation and Patient Teaching |
|
|
American College of Cardiology Evaluation of Preventive Therapeutics |
|
|
Aspirin and simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes |
|
|
Atorvastatin Comparative Cholesterol Efficacy and Safety Study |
|
|
Acute Candesartan Cilexetil Evaluation in Stroke Survivors |
|
|
Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension |
|
|
Action to Control Cardiovascular Risk in Diabetes |
|
|
Angioplastie Coronaire, Corvasal and Diltiazem |
|
|
Amlodipine Cardiovascular Community Trial |
|
|
ASA and Carotid Endarterectomy |
|
|
Asymptomatic Cardiac Ischemia Pilot study |
|
|
Aerobics Center Longitudinal Study |
|
|
Angioplasty Compared to Medicine |
|
|
Approaches to Chronic Occlusions with Sirolimus-eluting Stents/Total Occlusion Study of Coronary Arteries – 4 |
|
|
Antithrombotic Therapy in Acute Coronary Syndrome |
|
|
Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration – 2 |
|
|
A Coronary disease Trial Investigating Outcome with Nifedipine GITS |
|
|
Acute and Chronic Therapeutic Impact of a Vasopressin antagonist in Congestive Heart Failure |
|
|
Acyl-CoA:Cholesterol acyltransferase Intravascular Atherosclerosis Treatment Evaluation |
|
|
Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events |
|
|
Acute Catheterization and Urgent Intervention Triage Strategy |
|
|
Antithrombotic Combination Using Tirofiban and Enoxaparin II |
|
|
Antiarrhythmic Drug Evaluation Group |
|
|
Abciximab before Direct angioplasty and stenting in Myocardial Infarction Regarding Acute and Long-term follow-up |
|
|
AMP579 Delivery for Myocardial Infarction Reduction |
|
|
Arterial Disease Multiple Intervention Trial |
|
|
|
|
|
Action in Diabetes and Vascular disease; Preterax and Diamicron-MR Controlled Evaluation |
|
|
Addressing the Value of facilitated Angioplasty after Combination therapy or Eptifibatide monotherapy in acute Myocardial Infarction |
|
|
Adalat CR and Valsartan Cost-Effectiveness Combination |
|
|
Amlodipine Versus Angiotensin II receptor blocker: Control of blood pressure Evaluation trial in Diabetics – Japan |
|
|
Copenhagen Atrial Fibrillation, Aspirin and Anticoagulation |
|
|
Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation 2 |
|
|
Air Force/Texas Coronary Atherosclerosis Prevention Study |
|
|
Atrial Fibrillation and Congestive Heart Failure |
|
|
Atrial Fibrillation Follow-up Investigation of Rhythm Management |
|
|
Atrial Fibrillation Investigation with Bidisomide |
|
|
Aspirin/Anticoagulants Following Thrombolysis with anistreplase (Eminase) in Recurrent infarction |
|
|
Ashkelon Hypertension Detection and Control program |
|
|
APSAC Intervention Mortality Study |
|
|
ACE Inhibition in Progressive Renal Insufficiency |
|
|
Acute Infarction Ramipril Efficacy study |
|
|
AIRE Extension study |
|
|
Assessment of Lescol in Renal Transplantation |
|
|
Albumin in Acute Stroke |
|
|
Azimilide post-Infarct survival Evaluation |
|
|
Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial |
|
|
Aggressive Lipid-Lowering Initiation Abates New Cardiac Events |
|
|
Antihypertensive treatment and Lipid Profile In a North of Sweden Efficacy evaluation |
|
|
Assessment of Lipophilic vs hydrophilic Statin therapy in Acute Myocardial Infarction |
|
|
Austrian Multicenter Isradipine Cum Spirapril study |
|
|
Apolipoprotein-related Mortality Risk |
|
|
Australian National Blood Pressure study 2 |
|
|
Anemia in Chronic Heart failure: Outcomes and Resource utlization |
|
|
A randomized, Double-blind, double-dummy, multicentre, phase IIIb parallel-group study to compare the efficacy and safety of Rosuvastatin (10 mg and 20 mg) and atorvastatin (10 Mg and 20 mg) in patients with type 2 Diabetes mellitus |
|
|
Anticoagulation with rNAPc2 To Help Eliminate Major adverse cardiac events –Thrombolysis In Myocardial Infarction 32 |
|
|
Angiotensin II antagonist In Paroxysmal Atrial Fibrillation |
|
|
|
|
|
Assessment of Pexelizumab in Acute Myocardial Infarction |
|
|
Antihypertensive Patch Italian Study |
|
|
Arixtra (fondaparinux) combined with intermittent pneumatic compression vs intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery:
a randomized, double-blind comparison |
|
|
Apixaban for Prevention of Acute Ischemic and Safety Events |
|
|
Angiotensin-converting enzyme inhibition Post Revascularization Study |
|
|
Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis |
|
|
Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis – 2 |
|
|
Apixaban Prophylaxis in Patients undergoing total knee replacement Surgery |
|
|
Acebutolol et Prévention Secondaire de l’lnfarctus |
|
|
Angina Prognosis Study In Stockholm |
|
|
Ambulatory blood Pressure and Treatment of Hypertension |
|
|
Arginine in AMI |
|
|
Angiotensin II Receptor Antagonist Telmisartan in Isolated Systolic hypertension |
|
|
Arterial Biology for the Investigation of the Treatment Effects of Reducing cholesterol |
|
|
Arterial Biology for the Investigation of the Treatment Effects of Reducing cholesterol 2 |
|
|
Arterial Biology for the Investigation of the Treatment Effects of Reducing cholesterol 3 |
|
|
Arterial Biology for the Investigation of the Treatment Effects of Reducing cholesterol 6 – HDL and LDL Treatment Strategies |
|
|
Amiodarone Reduction in Coronary Heart disease |
|
|
Antiremodelling Effect of Aldosterone receptors blockade with canrenone In mild Chronic Heart Failure |
|
|
Argatroban and alteplase in patients with Acute Myocardial Infarction |
|
|
Arterial hypertension in the Group of elder patients |
|
|
Arterial hypertension in Group of high-risk patients – 2 |
|
|
|
|
|
Atherosclerosis Risk In Communities |
|
|
African American Rosuvastatin Investigation of Efficacy and Safety |
|
|
Ambrisentan in pulmonary arterial hypertension, Randomized, double-blind, placebo-controlled, multicenter, Efficacy Study 1 and 2 |
|
|
Attribution Randomisée énoxaparine/héparine/daltéparine pour évaluer les Marqueurs d’Activation cellulaire Dans l’Angor instable |
|
|
APSAC Reocclusion Multicentre Study |
|
|
Atorvastatin for Reduction of Myocardial Damage during Angioplasty – Acute Coronary Syndromes |
|
|
Atorvastatin for Reduction of Myocardial Damage during Angioplasty – Recapture |
|
|
Amiodarone for Resuscitation in Refractory Sustained Tachycardia |
|
|
Arterial Revascularisation Therapy Study |
|
|
Arterial Revascularisation Therapies Study II |
|
|
Acetylsalicylic Acid versus Anticoagulants |
|
|
Antioxidant Supplementation in Atherosclerosis Prevention |
|
|
Atorvastatin versus Simvastatin on Atherosclerosis Progression |
|
|
Asymptomatic Cervical Bruit |
|
|
Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure |
|
|
Aspirin non-responsiveness and Clopidogrel Endpoint Trial |
|
|
Anglo-Scandinavian Cardiac Outcomes Trial |
|
|
Accelerated Streptokinase and Enoxaparin |
|
|
Atherosclerosis and Folic Acid Supplementation Trial |
|
|
Atenolol Silent Ischemia Study |
|
|
Australian Streptokinase Trial |
|
|
Aspirin-induced platelet effect |
|
|
Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis |
|
|
Antithrombotics in the Secondary Prevention of Events in Coronary Thrombosis – 2 |
|
|
Atorvastatin as Prevention of CHD Endpoints in patients with Non-insulin dependent diabetes mellitus |
|
|
Arixtra Study in Percutaneous coronary Intervention: a Randomized Evaluation |
|
|
Action on Secondary Prevention through Intervention to Reduce Events |
|
|
Assessment of the Safety and Efficacy of a New Thrombolytic agent |
|
|
Assessment of the Safety and Efficacy of a New Thrombolytic – 1 |
|
|
Assessment of the Safety and Efficacy of a New Thrombolytic – 2 |
|
|
Assessment of the Safety and Efficacy of a New Thrombolytic – 3 |
|
|
Assessment of the Safety and Efficacy of a New Treatment strategy with Percutaneous Coronary Intervention |
|
|
Anglo-Scandinavian Study of Early Thrombolysis |
|
|
A Study To evaluate the Effect of Rosuvastatin On Intravascular ultrasound-Derived coronary atheroma burden |
|
|
Aortic Stenosis progression Observation: Measuring Effects of Rosuvastatin |
|
|
Antithrombotic Therapy in Acute Coronary Syndromes |
|
|
Alteplase and Tirofiban in Acute Myocardial Infarction |
|
|
Alpha-Tocopherol Beta-Carotene lung cancer prevention study |
|
|
Atorvastatin Goal achievement across risk levels |
|
|
A placebo-controlled, double-blind, parallel-arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patients with Atrial fibrillation/atrial flutter |
|
|
Athens Percutaneous Coronary Intervention |
|
|
Angiographic Trial using HMG CoA reductase inhibitor to Evaluate Retardation of Obstructive Multiple Atheroma |
|
|
Quinapril Titration Interval Management Evaluation |
|
|
Angina Treatments - Lasers And Normal Therapies In Comparison |
|
|
Acolysis during Treatment of Lesions Affecting Saphenous vein bypass grafts |
|
|
Assessment of Treatment with Lisinopril And Survival |
|
|
Antiplatelet Therapy vs Lovenox plus Antiplatelet therapy for patients with increased risk of Stent Thrombosis |
|
|
Atorvastatin versus bezafibrate in Mixed hyperlipidemia |
|
|
Anticoagulation and Risk factors In Atrial fibrillation |
|
|
Attenuation by Adenosine of Cardiac Complications |
|
|
Anti-TNF Therapy Against Congestive Heart failure |
|
|
Prise en charge de l’Artériopathie oblitérante des membres inférieurs chez les patients en médecine générale |
|
|
|
|
|
A study to evaluate the Use of Rosuvastatin in subjects On Regular haemodialysis: an Assessment of survival and cardiovascular events |
|
|
|
|
|
Atorvastatin Versus Revascularisation Treatments |
|
|
Antiarrhythmics Versus Implantable Defibrillators |
|
|
Azithromycin in Acute Coronary Syndrome |
|
